Related Experiment Video
Updated: Apr 12, 2026
07:42
Labeling Stem Cells with Fluorescent Dyes for non-invasive Detection with Optical Imaging
Published on: April 2, 2008
14.0K
Simple Methods for Tracking Stem Cells with (64)Cu-Labeled DOTA-hexadecyl-benzoate
Min Hwan Kim1, Sang-Keun Woo2, Kwang Il Kim2
1Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences , Seoul 139-706, Republic of Korea ; School of Life Sciences and Biotechnology, Korea University , Seoul 136-701, Republic of Korea.
ACS Medicinal Chemistry Letters
|May 26, 2015
Summary
This study introduces a novel Copper-64 labeled tracer, (64)Cu-DOTA-HB, for positron emission tomography (PET) imaging. This tracer effectively tracks transplanted adipose-derived stem cells (ADSCs) in vivo without compromising cell viability.
Area of Science:
- Nuclear Medicine
- Radiochemistry
- Biomedical Imaging
Background:
- Accurate monitoring of transplanted stem cells is crucial for regenerative medicine.
- Developing effective positron emission tomography (PET) radiotracers is essential for non-invasive stem cell tracking.
Purpose of the Study:
- To evaluate (64)Cu-labeled hexadecyl-1,4,7,10-tetraazacyclododecane-tetraacetic acid-benzoate ((64)Cu-DOTA-HB) as a PET radiotracer for stem cell imaging.
- To assess the efficiency and safety of (64)Cu-DOTA-HB for labeling and tracking adipose-derived stem cells (ADSCs).
Main Methods:
- Synthesis and (64)Cu labeling of hexadecyl-DOTA-benzoate (DOTA-HB).
- Cell labeling efficiency and viability assessment with ADSCs.
- In vivo PET imaging of intramuscularly transplanted (64)Cu-DOTA-HB labeled ADSCs in a rat heart model.
Main Results:
- High radiolabeling efficiency (>99%) of DOTA-HB with (64)Cu was achieved.
- Cell labeling efficiency with ADSCs exceeded 50% with no compromise to cell viability.
- Successful in vivo PET imaging and monitoring of transplanted ADSCs for 18 hours in the rat heart.
Conclusions:
- (64)Cu-DOTA-HB is a promising radiotracer for stem cell imaging.
- The developed tracer enables effective monitoring of transplanted stem cells using PET.
- This advancement holds potential for improving stem cell therapy efficacy assessment.
